Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRECIGEN, INC.PGEN · Entity 4356 | Chief Commercial Officer | August 23, 2026 | August 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRECIGEN, INC.
Report date August 23, 2026 · Filed August 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 141,992 |
Ending reported balance
After 2026-08-25 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-08-23 · Exercise / conversion · Acquired 5,208 · Balance 144,577 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Row 2 · 2026-08-23 · Tax withholding · Disposed 2,585 · Balance 141,992 F2: Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs. Row 3 · 2026-08-25 · Exercise / conversion · Acquired 79,166 · Balance 221,158 Row 4 · 2026-08-25 · Sale · Disposed 79,166 · Balance 141,992 F3: Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 57,292 |
Reported balance
After 2026-08-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-08-23 · Exercise / conversion · Disposed 5,208 · Balance 57,292 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F4: Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026. |
| Option to Purchase Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.61 · Expires 2034-07-22 | Direct | 120,834 |
Reported balance
After 2026-08-25 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-08-25 · Exercise / conversion · Disposed 79,166 · Balance 120,834 F5: The stock options vested 25% on July 22, 2025 and in equal monthly installments for three years thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F2: Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.
F3: Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
F4: Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026.
F5: The stock options vested 25% on July 22, 2025 and in equal monthly installments for three years thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2026 Filed Aug 25, 2026 21:25 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionOption to Purchase Common Stock (Right to Buy) · Derivative | 79,166 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0000950103-26-012871 · ownership.xml · derivative · entry 6 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,834 Underlying: Common Stock · 79,166 shares Expires 2034-07-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock options vested 25% on July 22, 2025 and in equal monthly installments for three years thereafter. Read SEC document |
| August 25, 2026 Filed Aug 25, 2026 21:25 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 79,166 | $7.50 | $593,745.00 |
DisclosureSEC source: 0000950103-26-012871 · ownership.xml · nonDerivative · entry 4 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,992 F3 · shares: Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person. Read SEC document |
| August 25, 2026 Filed Aug 25, 2026 21:25 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 79,166 | $1.61 | $127,457.26 |
DisclosureSEC source: 0000950103-26-012871 · ownership.xml · nonDerivative · entry 3 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 221,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2026 Filed Aug 25, 2026 21:25 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 5,208 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-26-012871 · ownership.xml · derivative · entry 5 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,292 Underlying: Common Stock · 5,208 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F4 · derivative.exercise_date: Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026. F4 · derivative.expiration_date: Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026. Read SEC document |
| August 23, 2026 Filed Aug 25, 2026 21:25 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Tax withholdingCommon Stock | 2,585 | $7.20 | $18,612.00 |
DisclosureSEC source: 0000950103-26-012871 · ownership.xml · nonDerivative · entry 2 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,992 F2 · shares: Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs. Read SEC document |
| August 23, 2026 Filed Aug 25, 2026 21:25 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 5,208 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-26-012871 · ownership.xml · nonDerivative · entry 1 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,577 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 20:28 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 30,272 | $4.36 | $131,985.92 |
DisclosureSEC source: 0000950103-26-008172 · ownership.xml · nonDerivative · entry 1 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,369 F1 · shares: Represents the number of shares of Precigen common stock sold pursuant to a sell-to-cover transaction to satisfy tax withholding obligations upon the vesting of restricted stock units on May 23, 2026. Read SEC document |
| May 23, 2026 Filed May 28, 2026 00:23 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-26-007844 · ownership.xml · derivative · entry 2 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: Represents 50% of the RSUs granted on June 26, 2025 that vested on May 23, 2026. The remaining RSUs will vest in equal quarterly installments for three years thereafter. F2 · derivative.expiration_date: Represents 50% of the RSUs granted on June 26, 2025 that vested on May 23, 2026. The remaining RSUs will vest in equal quarterly installments for three years thereafter. Read SEC document |
| May 23, 2026 Filed May 28, 2026 00:23 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 62,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-26-007844 · ownership.xml · nonDerivative · entry 1 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 20:20 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 115,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-26-006042 · ownership.xml · derivative · entry 2 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest 25% on May 23, 2027 and in equal six-month installments for three years thereafter. F3 · derivative.expiration_date: The RSUs vest 25% on May 23, 2027 and in equal six-month installments for three years thereafter. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 20:20 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 385,000 | $0.00 Strike: $4.11 | $0.00 |
DisclosureSEC source: 0000950103-26-006042 · ownership.xml · derivative · entry 1 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 385,000 Underlying: Common Stock · 385,000 shares Expires 2036-04-20 F1 · derivative.exercise_date: The options vest 25% on May 23, 2027 and in equal monthly installments for three years thereafter. Read SEC document |
| March 18, 2026 Filed Mar 20, 2026 23:32 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 42,110 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-26-004490 · dp243986_4-tennant.xml · derivative · entry 3 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,110 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vested immediately upon the grant date. F2 · derivative.expiration_date: The RSUs vested immediately upon the grant date. Read SEC document |
| March 18, 2026 Filed Mar 20, 2026 23:32 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 42,110 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-26-004490 · dp243986_4-tennant.xml · derivative · entry 2 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,110 Underlying: Common Stock · 42,110 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vested immediately upon the grant date. F2 · derivative.expiration_date: The RSUs vested immediately upon the grant date. Read SEC document |
| March 18, 2026 Filed Mar 20, 2026 23:32 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 42,110 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-26-004490 · dp243986_4-tennant.xml · nonDerivative · entry 1 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| September 29, 2025 Filed Sep 30, 2025 20:04 UTC | PRECIGEN, INC. PGEN · Entity 4356 | PurchaseCommon Stock | 6,000 | $3.58 | $21,480.00 |
DisclosureSEC source: 0000950103-25-012557 · dp235186_4-tennant.xml · nonDerivative · entry 1 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,031 Read SEC document |
| September 12, 2025 Filed Sep 16, 2025 23:42 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantPerformance Stock Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-25-011723 · dp234445_4-tennant.xml · derivative · entry 1 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · derivative.exercise_price: Represents the vesting of the second installment of performance stock units ("PSUs") originally granted on August 28, 2024 based on the achievement of the applicable performance condition for such installment. F2 · derivative.exercise_price: Each PSU is payable in a share of the Issuer's common stock or in a cash amount having an equivalent value. F1 · derivative.exercise_date: Represents the vesting of the second installment of performance stock units ("PSUs") originally granted on August 28, 2024 based on the achievement of the applicable performance condition for such installment. F2 · derivative.exercise_date: Each PSU is payable in a share of the Issuer's common stock or in a cash amount having an equivalent value. F1 · derivative.expiration_date: Represents the vesting of the second installment of performance stock units ("PSUs") originally granted on August 28, 2024 based on the achievement of the applicable performance condition for such installment. F2 · derivative.expiration_date: Each PSU is payable in a share of the Issuer's common stock or in a cash amount having an equivalent value. Read SEC document |
| June 26, 2025 Filed Jun 27, 2025 20:16 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-25-007995 · dp230755_4-tennant.xml · derivative · entry 1 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vest 50% on May 23, 2026 and in equal monthly installments for three years thereafter. F2 · derivative.expiration_date: The RSUs vest 50% on May 23, 2026 and in equal monthly installments for three years thereafter. Read SEC document |
| May 23, 2025 Filed May 27, 2025 23:25 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0000950103-25-006451 · dp229263_4-tennant.xml · derivative · entry 1 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2035-05-23 F1 · derivative.exercise_date: The options vest 50% on May 23, 2026 and in equal monthly installments for three years thereafter. Read SEC document |
| May 16, 2025 Filed May 17, 2025 00:06 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 66,441 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-25-006147 · dp228967_4-tennant.xml · derivative · entry 3 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 66,441 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vested in full on May 16, 2025. F3 · derivative.expiration_date: The RSUs vested in full on May 16, 2025. Read SEC document |
| May 16, 2025 Filed May 17, 2025 00:06 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Tax withholdingCommon Stock | 22,969 | $1.45 | $33,305.05 |
DisclosureSEC source: 0000950103-25-006147 · dp228967_4-tennant.xml · nonDerivative · entry 2 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,031 F2 · shares: Represents the number of shares of common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs. Read SEC document |
| May 16, 2025 Filed May 17, 2025 00:06 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 66,441 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-25-006147 · dp228967_4-tennant.xml · nonDerivative · entry 1 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| April 17, 2025 Filed Apr 18, 2025 21:06 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 66,441 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-25-005067 · dp227912_4-tennant.xml · derivative · entry 1 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,441 Underlying: Common Stock · 66,441 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs will vest in full on May 16, 2025. F2 · derivative.expiration_date: The RSUs will vest in full on May 16, 2025. Read SEC document |
| January 29, 2025 Filed Feb 4, 2025 01:14 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Tax withholdingCommon Stock | 9,441 | $1.30 | $12,273.30 |
DisclosureSEC source: 0000950103-25-001485 · dp224424_4-tennant.xml · nonDerivative · entry 2 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,559 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the PSUs. Read SEC document |
| January 29, 2025 Filed Feb 4, 2025 01:14 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-25-001485 · dp224424_4-tennant.xml · nonDerivative · entry 1 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 F1 · shares: Represent shares of Precigen common stock ("Common Stock") issued on settlement of the first installment of performance stock units ("PSUs") originally granted on August 28, 2024 that vested based on the achievement of the applicable performance condition for such installment. Read SEC document |
| July 22, 2024 Filed Jul 24, 2024 21:21 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0000950103-24-010674 · dp215150_4-tennant.xml · derivative · entry 1 Tennant Phil · CIK 0002030874 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2034-07-22 F1 · derivative.exercise_date: The options vest 25% on July 22, 2025 and in equal monthly installments for three years thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.